Eur Rev Med Pharmacol Sci 2022; 26 (17): 6129-6144

DOI: 10.26355/eurrev_202209_29631

Clinicopathologic and prognostic significance of long non-coding RNA myocardial infarction-associated transcript in multiple cancers

Y.-P. Zhang, Y.-W. Li, Y.-L. Dai, J. Zhou, Z.-M. Tu, B. Jiang, B. Wang

Department of Spine Surgery, Department of Orthopedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. wbxyeyy@csu.edu.cn


OBJECTIVE: The aim of the meta-analysis was to explore the clinicopathological and prognostic significance of long non-coding RNA (lncRNA) myocardial infarction-associated transcript (MIAT) in various cancers.

MATERIALS AND METHODS: We searched multiple databases, including PubMed, China National Knowledge 53 Infrastructure (CNKI), Springer, Web of Science, and Cochrane, for articles on the prognostic value of lncRNA MIAT in various cancers before 25 March 2021. The odds ratio (OR) and 95% confidence interval (CI) were adopted to evaluate the clinicopathological features and outcomes of cancers. The Cancer Genome Atlas dataset was used to identify the differential expression and prognostic significance of lncRNA MIAT.

RESULTS: We enrolled 14 publications, including 1,573 cancer patients. Higher lncRNA MIAT expression was significantly related to worse overall survival (OR=3.13, 95% CI: 2.47-3.96, p<0.05), regardless of cancer types, sample size, and follow-up time of the included studies. Additionally, higher lncRNA MIAT expression was associated with larger tumour sizes (OR=1.67, 95% CI: 1.24-2.26, p<0.05), advanced clinical stage (OR=4.79, 95% CI: 3.38-6.79, p<0.05), lymph nodes metastasis (OR=7.33, 95% CI: 4.61-11.67, p<0.05), and distant metastasis (OR=2.62, 95% CI: 1.88-3.66, p<0.05), but not associated with age and gender. We found no publication bias, and sensitivity analysis indicated that the results were reliable.

CONCLUSIONS: Higher lncRNA MIAT expression may predict larger tumour sizes, advanced clinical stage, metastasis of cancers, and lower overall survival rate. LncRNA MIAT may serve as a useful clinicopathological and prognostic biomarker for cancers.

Free PDF Download

To cite this article

Y.-P. Zhang, Y.-W. Li, Y.-L. Dai, J. Zhou, Z.-M. Tu, B. Jiang, B. Wang
Clinicopathologic and prognostic significance of long non-coding RNA myocardial infarction-associated transcript in multiple cancers

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 17
Pages: 6129-6144
DOI: 10.26355/eurrev_202209_29631